BioxyTran, Inc. filed a Form 8-K on November 5, 2026, disclosing that on November 4, 2026, the company announced it had secured an Attested Free Sale Certification for its product A-SUQAR, described as opening a path to the UAE and Gulf markets.
Key Highlights
- Certification obtained: BioxyTran disclosed it secured an Attested Free Sale Certification for A-SUQAR.
- Markets referenced: According to the filing, the certification opens "the Path to the UAE and Gulf Markets," per the press release title.
- Announcement vehicle: The company issued a press release over Globe Newswire on November 4, 2026, under the title "Bioxytran Secures Attested Free Sale Certification for A-SUQAR, Opening the Path to the UAE and Gulf Markets."
- Signatory: The filing was signed by David Platt, Ph.D., Chief Executive Officer of BioxyTran, Inc.
- Exchange listing: BioxyTran common stock, par value $0.001, trades on OTCQB under the symbol BIXT.
BioxyTran Discloses A-SUQAR Free Sale Certification in UAE-Focused Announcement
BioxyTran, Inc. (OTCQB:BIXT) filed a current report under Item 8.01 (Other Events) disclosing that on November 4, 2026, the company issued a press release via Globe Newswire announcing it had secured an Attested Free Sale Certification for its product A-SUQAR. The press release, included as Exhibit 99.1, carried the title "Bioxytran Secures Attested Free Sale Certification for A-SUQAR, Opening the Path to the UAE and Gulf Markets."
The filing does not provide additional details within the 8-K body itself beyond identifying the press release and its subject matter. The event date of the underlying development, as stated in the filing, is November 4, 2026. The company is incorporated in Nevada and maintains its principal executive offices at 75 Second Ave, Suite 605, Needham, MA 02494, according to the filing's cover page.
The filing was executed by David Platt, Ph.D., identified as Chief Executive Officer of BioxyTran, Inc. No financial statements were included. The only exhibits listed are the press release (Exhibit 99.1) and the Cover Page Interactive Data File embedded within the Inline XBRL document (Exhibit 104).
What Was Disclosed
BioxyTran, Inc. disclosed via an 8-K filing dated November 5, 2026, that it obtained an Attested Free Sale Certification for A-SUQAR and issued a related press release on November 4, 2026, referencing access to the UAE and Gulf markets.



Please wait processing your request...